Berkshire Hathaway has $189 billion in cash. Elon Musk has an idea where Warren Buffett should spend it.
By Steve Goldstein
The latest results from Berkshire Hathaway shows that the conglomerate had nearly $200 billion - $189 billion, to be precise -in cash at the end of the first quarter.
That's after Warren Buffett and co. trimmed its stakes in giants including Apple and Chevron. "We only swing at pitches we like," Buffett said this weekend.
Elon Musk has an idea on how some of that Berkshire Hathaway (BRK.B) cash can be deployed - Tesla (TSLA), which of course is the company he runs. "He should take a position in Tesla. It's an obvious move," said Musk in a message on the social media service X, which he owns.
Musk didn't explain why it would be obvious. Buffett, and his late partner, Charlie Munger, have praised the world's third-wealthiest billionaire previously. "What Tesla has done in the car business is a minor miracle," said Munger.
Tesla's financials are not the sort, however, to typically attract Buffett.
According to FactSet, Tesla trades at 66 times next year's earnings, at 9 times book and 57 times cash flow, which compared to Tesla's own history is significantly cheaper than its highs but elevated compared to other companies in the field. The second-biggest automaker by market cap, Toyota (TM), trades at 10 times next year's earnings, a little more than 1 times book and 11 times cash flow.
Musk has previously recalled meeting Munger - in one message, saying the meeting was in late 2008, in another, saying it was in 2009.
"I was at a lunch with Munger in 2009 where he told the whole table all the ways Tesla would fail," said Musk. "Made me quite sad, but I told him I agreed with all those reasons & that we would probably die, but it was worth trying anyway."
Tesla shares have dropped 27% this year even after rallying 29% from its late April lows.
Tesla stock rose 1% in premarket trade.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-06-24 0822ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing